National Health Investors (NYSE:NHI – Get Free Report) had its price target reduced by equities research analysts at Truist Financial from $92.00 to $89.00 in a report released on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the real estate investment trust’s stock. Truist Financial’s target price points to a potential upside of 6.79% from the stock’s previous close.
A number of other equities research analysts also recently issued reports on the stock. Weiss Ratings reissued a “buy (b)” rating on shares of National Health Investors in a research note on Friday, March 27th. National Bank Financial set a $85.00 price target on shares of National Health Investors in a research note on Tuesday, January 20th. Cantor Fitzgerald set a $85.00 price target on shares of National Health Investors in a research note on Monday, January 5th. Deutsche Bank Aktiengesellschaft downgraded shares of National Health Investors from a “buy” rating to a “hold” rating and set a $85.00 price target on the stock. in a research note on Tuesday, January 20th. Finally, Wells Fargo & Company boosted their price target on shares of National Health Investors from $85.00 to $86.00 and gave the company an “equal weight” rating in a research note on Friday, March 27th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, National Health Investors presently has an average rating of “Moderate Buy” and an average target price of $86.33.
National Health Investors Price Performance
National Health Investors (NYSE:NHI – Get Free Report) last issued its earnings results on Thursday, February 26th. The real estate investment trust reported $1.22 EPS for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.01). The firm had revenue of $105.82 million for the quarter, compared to analysts’ expectations of $95.12 million. National Health Investors had a return on equity of 9.56% and a net margin of 37.81%.National Health Investors’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same period last year, the firm earned $1.24 earnings per share. National Health Investors has set its FY 2026 guidance at 4.940-4.990 EPS. Analysts predict that National Health Investors will post 5.05 earnings per share for the current year.
Institutional Investors Weigh In On National Health Investors
Several large investors have recently added to or reduced their stakes in the business. Renaissance Group LLC increased its stake in National Health Investors by 3.8% during the 4th quarter. Renaissance Group LLC now owns 3,206 shares of the real estate investment trust’s stock worth $245,000 after buying an additional 117 shares during the period. GAMMA Investing LLC increased its stake in National Health Investors by 41.8% during the 4th quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust’s stock worth $35,000 after buying an additional 136 shares during the period. Captrust Financial Advisors increased its stake in National Health Investors by 1.7% during the 4th quarter. Captrust Financial Advisors now owns 8,907 shares of the real estate investment trust’s stock worth $680,000 after buying an additional 146 shares during the period. PNC Financial Services Group Inc. increased its stake in National Health Investors by 5.0% during the 3rd quarter. PNC Financial Services Group Inc. now owns 3,731 shares of the real estate investment trust’s stock worth $297,000 after buying an additional 177 shares during the period. Finally, Arizona State Retirement System increased its stake in National Health Investors by 1.4% during the 3rd quarter. Arizona State Retirement System now owns 13,818 shares of the real estate investment trust’s stock worth $1,099,000 after buying an additional 191 shares during the period. 62.51% of the stock is owned by hedge funds and other institutional investors.
About National Health Investors
National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.
Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.
Featured Articles
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.
